The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer and Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.
The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer and Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.
Biosens Bioelectron. 2025 Jan 1;267:116801. doi: 10.1016/j.bios.2024.116801. Epub 2024 Sep 25.
Image-guided surgery is crucial for achieving complete tumor resection, reducing postoperative recurrence and improving patient survival. However, current clinical near-infrared fluorescent probes, such as indocyanine green (ICG), face two main limitations: 1) lack of active tumor targeting, and 2) short retention time in tumors, which restricts real-time imaging during surgery. To address these issues, we developed a near-infrared fluorescent probe capable of in situ nanofiber formation within tumor lesions. This probe actively targets the integrin αβ receptors overexpressed on breast cancer cells and exhibits assembly/aggregation-induced retention effects at the tumor site, significantly extending the imaging time window. Additionally, we found that the probe's fluorescence intensity can be enhanced under receptor induction. Due to its excellent tumor specificity and sensitivity, 1FCG-FFGRGD not only identifies primary breast cancer but also precisely locates smaller lymph node metastases and detects sub-millimeter peritoneal metastases. In summary, this near-infrared probe, leveraging assembly/aggregation-induced retention effects, holds substantial potential for various biomedical applications.
影像引导手术对于实现肿瘤的完全切除、降低术后复发率和提高患者生存率至关重要。然而,目前临床应用的近红外荧光探针,如吲哚菁绿(ICG),存在两个主要局限性:1)缺乏主动肿瘤靶向性,2)在肿瘤中的保留时间短,这限制了手术过程中的实时成像。为了解决这些问题,我们开发了一种能够在肿瘤病变部位原位形成纳米纤维的近红外荧光探针。该探针主动靶向过度表达于乳腺癌细胞上的整合素 αβ 受体,并在肿瘤部位表现出组装/聚集诱导保留效应,显著延长了成像时间窗口。此外,我们发现探针的荧光强度可以在受体诱导下增强。由于其出色的肿瘤特异性和灵敏度,1FCG-FFGRGD 不仅可以识别原发性乳腺癌,还可以精确定位较小的淋巴结转移,并检测亚毫米级的腹膜转移。总之,这种基于组装/聚集诱导保留效应的近红外探针在各种生物医学应用中具有很大的潜力。